Trump Signs Executive Order to Reduce US Reliance on China for Medicine

By Emel Akan
Emel Akan
Emel Akan
Emel Akan is a senior White House correspondent for The Epoch Times, where she covers the Biden administration. Prior to this role, she covered the economic policies of the Trump administration. Previously, she worked in the financial sector as an investment banker at JPMorgan. She graduated with a master’s degree in business administration from Georgetown University.
August 6, 2020Updated: August 6, 2020

WASHINGTON—In response to supply disruptions caused by the pandemic, President Donald Trump signed an executive order on Aug. 6 in Clyde, Ohio, to ensure that essential medicines, medical supplies, and equipment are made in the United States.

Speaking at Whirlpool Corporation’s manufacturing facility in northwest Ohio, Trump said, “We’ll end reliance on China just like we did with the washers and dryers.”

“As we celebrate Whirlpool’s 109-year legacy of American Manufacturing excellence, today I want to lay out my vision to bring millions more jobs and thousands more factories back to American shores, where they belong.”

In 2018, Trump imposed tariffs on imported washers to help domestic manufacturers such as Whirlpool, a Michigan-based manufacturer.

As a result of the tariffs, Trump said Whirlpool’s nine factories across the country have thrived.

“During the course of the next four years, we will bring our pharmaceutical and medical supply chains home,” Trump said. “We cannot rely on China and other nations across the globe.”

In order to prevent medical supply chain disruptions in the future, Trump signed the executive order called “Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs are Made in the United States.”

The broad executive order covers medicines as well as medical supplies, including masks, gloves, and goggles, and medical equipment such as ventilators.

It has three components, which include the “Buy American” order to ensure that government agencies, including the departments of Veterans Affairs, Health and Human Services, and Defense, buy American products.

The order aims to increase government demand for U.S.-made products to help create a market for manufacturers to invest and to produce in the United States.

The second component of the order is deregulation, which ensures the Food and Drug Administration and the U.S. Environmental Protection Agency ease rules for the development of advanced manufacturing facilities in the United States.

This will help create “a more rational and streamlined regulatory process” to address national security threats in a timely fashion, according to White House trade adviser Peter Navarro who briefed reporters earlier about the executive order.

The third component of the order, which is critical to keeping drug prices down, is “to catalyze advanced manufacturing and continuous manufacturing techniques,” Navarro said. The objective is to create economies of scale and scope to help reduce the cost of production in the United States.

Besides essential medicines, medical countermeasures are also a key part of this order, as they are crucial to fighting national security threats, including chemical, biological, radiological, nuclear, and pandemic threats.

In addition, the executive order will help combat the trafficking of counterfeit medicines coming primarily from China.

In a campaign-style speech in Ohio, Trump criticized previous administrations for letting “foreign nations steal our jobs, loot our factories, and plunder the crown jewels of the U.S. economy.”

“The Obama-Biden administration was perfectly happy to let China win, your jobs disappear, and your factory close,” he said.

Besides the medical supply chains, Trump said he would take similar actions to onshore manufacturing across other critical sectors, including electronics, machine tools, shipping, aerospace, autos, iron, and steel.

The pandemic has disrupted the U.S. pharmaceutical industry’s global supply chain, which is largely dependent on China, calling attention to a dangerous level of dependence by the United States on this global competitor.

China is the dominant supplier of thousands of medicines found in U.S. homes and hospitals, from antibiotics to chemotherapies, from HIV/AIDS drugs to antidepressants and painkillers. That has made the United States vulnerable to supply-chain disruptions arising from the pandemic.

China also has a dominant market share in personal protective equipment, such as masks, respirators, surgical gowns, and gloves, which are currently in high demand. During the pandemic, countries where production facilities are located have imposed export restrictions for critically needed items, which has alarmed the U.S. government.

Trump’s new executive order will help “jumpstart domestic manufacturing of critical drugs and their components,” according to Rosemary Gibson, the co-author of the book “China Rx” and a senior adviser at the Hastings Center, a bioethics research institute.

“The United States had shortages of critical drugs for more than 20 years under Democratic and Republican administrations,” she said. “And nobody did anything about that for years.”